
Sangeetha Palakurthi
Experienced, Innovative, Oncology- Pharmacology leader with a track record of delivery at all stages of drug discovery from... | Cambridge, Massachusetts, United States
*50 free lookup(s) per month.
No credit card required.
Sangeetha Palakurthi’s Emails sa****@el****.com
Sangeetha Palakurthi’s Phone Numbers No phone number available.
Social Media
Sangeetha Palakurthi’s Location Cambridge, Massachusetts, United States
Sangeetha Palakurthi’s Expertise Experienced, Innovative, Oncology- Pharmacology leader with a track record of delivery at all stages of drug discovery from target identification and validation of new targets through to candidate drug nomination. Successfully lead the preclinical pharmacology of various oncology, IO drug discovery programs targeting diverse pathways and delivered a candidate to clinical trials. Effective team player experienced in working collaboratively with multidisciplinary candidate drug delivery teams and contributing to key milestone relevant strategies. Scientific expertise in Oncogenic pathways, patient stratification and Haem-Onc disease knowledge. Specialties: PK-PD Human dose predictions Translatable Biomarkers Target validation Patient stratification Drug combinations Mouse models of cancer In vivo Pharmacology Immuno-oncology
Sangeetha Palakurthi’s Current Industry Kojin Therapeutics
Sangeetha
Palakurthi’s Prior Industry
Dr Reddys Laboratories
|
Harvard Medical School
|
Astrazeneca
|
Astellas Pharma
|
Dana Farber Cancer Institute
|
Marengo Therapeutics
|
Omega Therapeutics
|
Self Employed
|
Kojin Therapeutics
Not the Sangeetha Palakurthi you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Kojin Therapeutics
Vice President, Pharmacology
Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Self Employed
Independent Consultant
Sat Apr 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Omega Therapeutics
Vice President, Cancer Biology
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Feb 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Marengo Therapeutics
Vice President, In Vivo Pharmacology and Translational Science
Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Marengo Therapeutics
Vice President, In Vivo Pharmacology
Thu Nov 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Marengo Therapeutics
Director, In Vivo Pharmacology
Thu Jun 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Oct 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Dana Farber Cancer Institute
Head, Cancer Biology and Pharmacology
Thu Nov 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon May 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Astellas Pharma
Senior Research Investigator (Head of Translational Pharmacology)
Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Sep 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Astrazeneca
Senior Scientist, Oncology - In Vivo Pharmacology,
Thu Sep 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jun 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Astrazeneca
Scientist, Oncology- Cell Biology- lead generation group
Thu Nov 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Harvard Medical School
Post doctoral Research Associate
Fri Nov 01 1996 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Oct 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Dr Reddys Laboratories
Scientist-Oncology
Wed Jun 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 1996 00:00:00 GMT+0000 (Coordinated Universal Time)